These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29165389)

  • 1. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.
    Ungefroren H; Witte D; Rauch BH; Settmacher U; Lehnert H; Gieseler F; Kaufmann R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
    Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
    Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.
    Ungefroren H; Gieseler F; Kaufmann R; Settmacher U; Lehnert H; Rauch BH
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor-
    Ungefroren H; Witte D; Mihara K; Rauch BH; Henklein P; Jöhren O; Bonni S; Settmacher U; Lehnert H; Hollenberg MD; Kaufmann R; Gieseler F
    Mol Pharmacol; 2017 Nov; 92(5):519-532. PubMed ID: 28842394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer.
    Witte D; Zeeh F; Gädeken T; Gieseler F; Rauch BH; Settmacher U; Kaufmann R; Lehnert H; Ungefroren H
    J Clin Med; 2016 Nov; 5(12):. PubMed ID: 27916875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.
    Ungefroren H; Witte D; Fiedler C; Gädeken T; Kaufmann R; Lehnert H; Gieseler F; Rauch BH
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.
    Chung H; Ramachandran R; Hollenberg MD; Muruve DA
    J Biol Chem; 2013 Dec; 288(52):37319-31. PubMed ID: 24253040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
    Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFBR1 and cancer susceptibility.
    Pasche B; Pennison MJ; Jimenez H; Wang M
    Trans Am Clin Climatol Assoc; 2014; 125():300-12. PubMed ID: 25125747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
    Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
    Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
    Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
    Chen T; Yan W; Wells RG; Rimm DL; McNiff J; Leffell D; Reiss M
    Int J Cancer; 2001 Sep; 93(5):653-61. PubMed ID: 11477574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.